Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Grever

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1985
Low-dose deoxycoformycin in lymphoid malignancyM R Grever, J M Leiby, E H Kraut, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-ELM E Dolan, A E Pegg, R C Moschel, et al.
Cancer Treatment Reports|July 1, 1987
Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group StudyD H Ryan, K J Kopecky, D Head, et al.
Blood|August 10, 1999
Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cellsJ C Byrd, C Shinn, R Ravi, et al.
Journal of the National Cancer Institute|September 18, 1991
Summary of the workshop on Drug Development, Biological Diversity, and Economic GrowthJ Schweitzer, F G Handley, J Edwards, et al.
Journal of the National Cancer Institute|December 21, 1994
Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor modelJ J Casciari, M G Hollingshead, M C Alley, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Phase I study of 5-aza-2'-deoxycytidine in combination with valproic acid in non-small-cell lung cancerB F Chu, M J Karpenko, Z Liu, et al.
Blood|March 1, 1981
The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancyM R Grever, M F Siaw, W F Jacob, et al.
Seminars in Oncology|July 6, 2000
Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disordersJ C Byrd, M R Grever, J K Waselenko, et al.
Journal of the National Cancer Institute|January 4, 1995
Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeletonA M Senderowicz, G Kaur, E Sainz, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1985
Low-dose deoxycoformycin in lymphoid malignancyM R Grever, J M Leiby, E H Kraut, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biodistribution of O6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-ELM E Dolan, A E Pegg, R C Moschel, et al.
Cancer Treatment Reports|July 1, 1987
Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group StudyD H Ryan, K J Kopecky, D Head, et al.
Blood|August 10, 1999
Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cellsJ C Byrd, C Shinn, R Ravi, et al.
Journal of the National Cancer Institute|September 18, 1991
Summary of the workshop on Drug Development, Biological Diversity, and Economic GrowthJ Schweitzer, F G Handley, J Edwards, et al.
Journal of the National Cancer Institute|December 21, 1994
Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor modelJ J Casciari, M G Hollingshead, M C Alley, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Phase I study of 5-aza-2'-deoxycytidine in combination with valproic acid in non-small-cell lung cancerB F Chu, M J Karpenko, Z Liu, et al.
Blood|March 1, 1981
The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancyM R Grever, M F Siaw, W F Jacob, et al.
Seminars in Oncology|July 6, 2000
Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disordersJ C Byrd, M R Grever, J K Waselenko, et al.
Journal of the National Cancer Institute|January 4, 1995
Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeletonA M Senderowicz, G Kaur, E Sainz, et al.
Pageof 10